ARTICLES BY RAJENDRAN (RAJ) ARUNAGIRI

• We Must Rethink The Solvents We Use For Peptide Synthesis

  4/21/2025

  While the effectiveness of GLP-1 in weight loss is good news, the use of organic solvents in the GLP-1 synthesis and purification process is a growing pain that needs to be addressed.

• 4 Tips To Leverage Your Ingredient Supplier For Faster Formulation

  8/3/2023

  Speed to formulation plays a critical role in recouping the investment for a new drug. Many ingredient suppliers have an experienced analytical group and material scientist group, and drug developers should reach out and leverage that expertise with these four strategies.

• 3 Action Items For The US Bio/Pharma Industry To Mitigate Supply Vulnerabilities

  6/12/2023

  The United States’ reliance on foreign manufacturers of API has been a known fact for several years. We can mitigate our supply vulnerabilities, but bio/pharma companies and the FDA both have roles to fill in this need.

• Addressing 3 Challenges Of Developing Or Using A New Excipient

  5/8/2023

  As the world discovers new molecular entities, new solutions for and innovation of excipients are more critical than ever. However, they are often overlooked. Let’s look at how to address three key challenges: risk aversion, an inconsistent feedback loop between pharma companies and excipient suppliers, and the current lack of regulatory body-backed innovation programs.